The abundance of CD8+ T cells and FoxP3+ T regulatory cells (Tregs), as well as PD-L1 expression by tumor and stromal cells in the tumor microenvironment (TME), are predictors of prognosis and response to immunotherapy in human NSCLC and melanoma (22). This evidence concerns the gene CD274 and non-small cell lung carcinoma.